Clinical trial
Role of Neutrophil Activation in Anaphylaxis to Neuro-Muscular Blocking Agents
NCT01637220 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of Neutrophil Activation in Anaphylaxis to Neuro-Muscular Blocking Agents
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- December 31, 2015
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anaphylactic shock to neuro-muscular blocking agents (nmba)